HSPA1A and glioblastoma: Because our work is directed toward the identification of biomarkers for the early diagnosis of GBM, we focused on CACLR, considering its cellular functions as a tumor suppressor, which are currently little known, and its ability to interact with various chaperone molecules, including some belonging to the Hsp70 family (Figure 4B).